Development of pancytopenia after single low-dose methotrexate therapy in patients with chronic kidney disease: a review of the literature
Methotrexate (MTX) is widely used in the treatment of both rheumatoid arthritis (RA) and psoriatic arthritis (PA) with a side effect of pancytopenia. However, very few cases of severe pancytopenia caused by low-dose MTX therapy have been described in chronic kidney disease. Pancytopenia occurred aft...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nizameddin KOCA
2020-07-01
|
| Colección: | Turkish Journal of Internal Medicine |
| Materias: | |
| Acceso en línea: | https://dergipark.org.tr/tr/download/article-file/1219248 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|